The intestinal immune system is vital for maintaining mucosal homeostasis and mediating interactions between the host and its ...

Cash balance of $58.0 million as of March 31, 2025 anticipated to fund key milestones through mid-2026 ...

A study of more than 100 patients found that immunotherapy can cure a rare type of cancer in various tumor sites without ...

Immunity is not a function most people particularly associate with the liver. But because of its connection to the gut, the ...

The immune system can work in two ways: the innate immune system reacts to any foreign invaders that are identified by immune cells that look... | Cell And Molecular Biology ...

New research has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer. The findings offer new ...

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...

Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) and local biotechnology company Intra-ImmuSG ...

WTX-124 Phase 1/1b clinical trial on track for data readouts and interactions with the FDA in the second half of the year - - First patient dosed in the Phase 1b/2 clinical trial of WTX-330, seeking ...

Ubiquitination, an essential post-translational modification, controls various cellular functions by attaching ubiquitin to proteins, dictating their fate from degradation to functional reorganization ...

During the second half of 2025, Werewolf plans to present interim data from the monotherapy and combination expansion arms, including tolerability, response rate, and durability, and to engage with ...

The leading Merkel Cell Carcinoma Companies such as ImmunityBio, OncoSec Medical, Exelixis, 4SC, Kartos Therapeutics, Incyte ...